HCV genotype-3a T cell immunity: specificity, function and impact of therapy.

HCV genotype-3a T cell immunity: specificity, function and impact of therapy.

Show other versions (2)

BACKGROUND: Hepatitis C virus (HCV) genotype-3a infection is now the dominant strain in South Asia and the UK. Characteristic features include a favourable response to therapy; the reasons for this are unknown but may include distinct genotype-3a-specific T cell immunity. In contrast to genotype-1 i...

Full description

Bibliographic Details
Main Authors:	Humphreys, I, von Delft, A, Brown, A, Hibbert, L, Collier, J, Foster, G, Rahman, M, Christian, A, Klenerman, P, Barnes, E
Format:	Journal article
Language:	English
Published:	2012

Similar Items

HCV genotype-3a T cell immunity: specificity, function and impact of therapy
by: Humphreys, IS, et al.
Published: (2012)

HCV genotype-3a T cell immunity: Specificity, function and impact of therapy
by: Humphreys, I, et al.
Published: (2012)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
by: von Delft, A, et al.
Published: (2014)

Immune responses in acute and chronic HCV genotype 3a infection detected by two distinct techniques
by: von Delft, A, et al.
Published: (2011)

A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
by: Donnison, T, et al.
Published: (2018)

IL28B GENETIC STATUS IN ASSOCIATION WITH HCV SPECIFIC T-CELL IMMUNITY
by: Bucci, C, et al.
Published: (2011)

The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
by: von Delft, A, et al.
Published: (2015)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
by: von Delft, A, et al.
Published: (2017)

The global distribution and prevalence of HCV genotypes
by: Messina, J, et al.
Published: (2014)

Full-length sequence analysis of HCV genotype-3A reveals novel regions of hypervariability
by: Humphreys, I, et al.
Published: (2007)

Hepatitis C virus (HCV) cellular immune responses are induced during combination therapy but are not sustained.
by: Barnes, E, et al.
Published: (2000)

MULTIPLE NOVEL PEPTIDE EPITOPES IN HCV GENOTYPE-3A IDENTIFIED USING TWO PARALLEL APPROACHES
by: Boehmer, A, et al.
Published: (2011)

High dose interferon-alpha induction therapy is associated with a profound loss of IL-2 and IFN-gamma secreting HCV specific T-cells
by: Gelderblom, H, et al.
Published: (2007)

HCV-specific T-CELL responses of acutely HCV infected individuals with and without HIV.
by: Danta, M, et al.
Published: (2005)

Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
by: Julia L. Casey, et al.
Published: (2019-04-01)

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.
by: Katsoulidou, A, et al.
Published: (2006)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
by: Rohrbach, J, et al.
Published: (2010)

HCV immunology--death and the maiden T cell.
by: Willberg, C, et al.
Published: (2003)

Ever closer to a prophylactic vaccine for HCV.
by: Swadling, L, et al.
Published: (2013)

Methodologies for the analysis of HCV-specific CD4(+) T cells
by: Lokhande, M, et al.
Published: (2015)

VIROLOGICAL RESPONSES TO COMBINATION THERAPY IN PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1B ARE RELATED WITH DYNAMIC OF HCV-NS-SPECIFIC T CELL RESPONSES
by: Zhang, Y, et al.
Published: (2010)

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
by: Asad Sultan, et al.
Published: (2011-06-01)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
by: Pellicelli Adriano M, et al.
Published: (2012-11-01)

Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
by: Lauer, G, et al.
Published: (2001)

Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population
by: Allain, J, et al.
Published: (2006)

UPREGULATION OF REGULATORY T CELLS AND REDUCTION OF ANTI-VIRAL IMMUNE RESPONSES TO HEPATITIS C DURING VIRAL ERADICATION IN PATIENTS UNDERGOING ANTIVIRAL TREATMENT
by: Hibbert, L, et al.
Published: (2009)

Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
by: M.G. Deneke, et al.
Published: (2014-01-01)

Highly immunogenic virally vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
by: Swadling, L, et al.
Published: (2016)

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection
by: Swadling, L, et al.
Published: (2016)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
by: Shrikant Dasharath Warkad, et al.
Published: (2018-07-01)

Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population.
by: Chuang, W, et al.
Published: (2007)

A THERAPEUTIC VACCINE FOR HCV BASED ON NOVEL, RARE, ADENOVIRAL VECTORS
by: Kelly, C, et al.
Published: (2011)

Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy.
by: Semmo, N, et al.
Published: (2006)

Cellular immune responses against HCV: T cells take a diversion in the liver
by: Klenerman, P, et al.
Published: (2004)

Methodologies for the analysis of HCV-specific CD4+ T cells
by: Megha eLokhande, et al.
Published: (2015-02-01)

Viral dynamics among HCV infected patients with different genotypes treated with genotypic specific or pan-genotypic direct-acting antiviral agent combinations
by: Paolucci S, et al.
Published: (2019-07-01)

HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma.
by: Ping Qiu, et al.
Published: (2015-01-01)

HCV and HBV genotypes: vital in the progression of HCV/ HBV co-infection
by: Yasmin Badshah, et al.
Published: (2025-01-01)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
by: Ahmad Habib, et al.
Published: (2011-10-01)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution
by: Kasprowicz, V, et al.
Published: (2011)